Skip to main content
SpringerLink
Log in

Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Ventricular access devices (VAD) offer several advantages compared to intralumbar injections for the administration of intra-CSF agents in the treatment of leptomeningeal metastases (LM). However, there are few prospective studies reporting on complications with the use of VADs. All complications were prospectively collected that pertained to the implantation and use of a VAD in consecutive patients with solid tumor-related LM from June 2006 to December 2013. Clinical follow-up was every 2 weeks during the initial 2 months of treatment and then once monthly. Complete neuraxis MRI was performed at baseline and then every 2–3 months. A total of 112 patients (88 women) with a mean age of 51.1 years (range 26–73) were included. Primary cancers included breast (79 patients), lung (12) and melanoma (6). All patients were treated with intra-CSF liposomal cytarabine. 72 % of the patients received concomitant systemic and intra-CSF chemotherapy. The placement of the VAD was performed under local anesthesia in all cases. The mean operative time was 15 min and no perioperative complications were reported. The mean number of intraventricular injections per patient was 9.34 (range 1–47). A total of 11 complications in 11 patients were seen including 7 infections, 1 intracranial hemorrhage, 2 instances of symptomatic leukoencephalopathy and 1 catheter malpositioning. 8 complications required an operation and 1 complication was fatal. The use of a VAD is safe and may improve patients’ comfort and compliance with LM-directed therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Yap HY, Yap BS, Tashima CK, DiStefano A, Blumenschein GR (1978) Meningeal carcinomatosis in breast cancer. Cancer 42:283–286

    Article  CAS  PubMed  Google Scholar 

  2. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK (1978) Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 42:660–668

    Article  CAS  PubMed  Google Scholar 

  3. Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25:103–119

    Article  CAS  PubMed  Google Scholar 

  4. Le Rhun E, Taillibert S, Chamberlain MC (2013) Carcinomatous meningitis: leptomeningeal metastases in solid tumors. Surg Neurol Int 4:S265–S288

    PubMed Central  PubMed  Google Scholar 

  5. Chamberlain MC (2005) Neoplastic meningitis. J Clin Oncol 23:3605–3613

    Article  PubMed  Google Scholar 

  6. DeAngelis LM (1998) Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 38:245–252

    Article  CAS  PubMed  Google Scholar 

  7. Blaney SM, Poplack DG (2000) Neoplastic meningitis: diagnosis and treatment considerations. Med Oncol 17:151–162

    Article  CAS  PubMed  Google Scholar 

  8. Pace P, Fabi A (2006) Chemotherapy in neoplastic meningitis. Crit Rev Oncol Hematol 60:528–534

    Article  Google Scholar 

  9. Brem SS, Bierman PJ, Black P, Blumenthal DT, Brem H, Chamberlain MC et al (2008) Central nervous system cancers: clinical practice guidelines in oncology. J Natl Compr Cancer Netw 6:456–504

    CAS  Google Scholar 

  10. Bokstein F, Lossos A, Siegal T (1998) Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer 82:1756–1763

    Article  CAS  PubMed  Google Scholar 

  11. Chamberlain MC (2009) Leptomeningeal metastasis. Curr Opin Neurol 22:665–674

    Article  CAS  PubMed  Google Scholar 

  12. Glantz MJ, Van Horn A, Fisher R, Chamberlain MC (2010) Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis. Cancer 116:1947–1952

    Article  PubMed  Google Scholar 

  13. Shapiro WR, Young DF, Mehta BM (1975) Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 293:161–166

    Article  CAS  PubMed  Google Scholar 

  14. Ratcheson RA, Ommaya AK (1968) Experience with the subcutaneous cerebrospinal-fluid reservoir. Preliminary report of 60 cases. N Engl J Med 279:1025–1031

    Article  CAS  PubMed  Google Scholar 

  15. Obbens EA, Leavens ME, Bed JW, Lee YY (1985) Ommaya reservoirs in 387 cancer patients. A 15-year experience. Neurology 35:1274

    Article  CAS  PubMed  Google Scholar 

  16. Sandberg DI, Bilsky MH, Souweidane MM, Bzdil J, Gutin PH (2000) Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery 47:49–55

    CAS  PubMed  Google Scholar 

  17. Ommaya AK (1963) Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. Lancet 282:983–984

    Article  Google Scholar 

  18. Lishner M, Perrin RG, Feld R, Messner HA, Tuffnell PG, Elhakim T, Matlow A, Curtis JE (1990) Complications associated with Ommaya reservoirs in patients with cancer: the Princess Margaret Hospital experience and review of the literature. Arch Intern Med 150:173

    Article  CAS  PubMed  Google Scholar 

  19. Bleyer WA, Pizzo PA, Spence AM, Platt WD, Benjamin DR, Kolins CJ, Poplack DG (1978) The Ommaya reservoir. Newly recognized complications and recommendations for insertion and use. Cancer 41:2431–2437

    Article  CAS  PubMed  Google Scholar 

  20. Zairi F, Le Rhun E, Tetard MC, Kotecki N, Assaker R (2011) Complications related to the placement of an intraventricular chemotherapy device. J Neurooncol 104:247–252

    Article  PubMed  Google Scholar 

  21. Balm M, Hammack J (1996) Leptomeningeal carcinomatosis: presenting features and prognostic factors. Arch Neurol 53:626–632

    Article  CAS  PubMed  Google Scholar 

  22. Glantz MJ, Cole BF, Glantz LK, Cobb J, Mills P, Lekos A, Walters BC, Recht LD (1998) Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 82:733–739

    Article  CAS  PubMed  Google Scholar 

  23. Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA et al (2011) National comprehensive cancer network, central nervous system. J Natl Compr Canc Netw 9:352–400

    PubMed  Google Scholar 

  24. Jaeckle KA (2006) Neoplastic meningitis from systemic malignancies: diagnosis, prognosis, and treatment. Semin Oncol 33:312–323

    Article  PubMed  Google Scholar 

  25. Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM (2010) Leptomeningeal metastases in the MRI era. Neurology 74:1449–1454

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Chamberlain MC, Kormanik PA, Barba D (1997) Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg 87:694–699

    Article  CAS  PubMed  Google Scholar 

  27. Pirotte BJ, Lubansu A, Bruneau M, Loqa C, Van Cutsem N, Brotchi J (2007) Sterile surgical technique for shunt placement reduces the shunt infection rate in children: preliminary analysis of a prospective protocol in 115 consecutive procedures. Childs Nerv Syst 23:1251–1261

    Article  PubMed  Google Scholar 

  28. Mead PA, Safdieh JE, Nizza P, Tuma S, Sepkowitz KA (2014) Ommaya reservoir infections: a 16-year retrospective analysis. J Infect 68:225–230

    Article  PubMed  Google Scholar 

  29. Szvalb AD, Raad II, Weinberg JS, Suki D, Mayer R, Viola GM (2014) Ommaya reservoir-related infections: clinical manifestations and treatment outcomes. J Infect 68:216–224

    Article  PubMed  Google Scholar 

  30. Kosier MB, Minkler P (1999) Nursing management of patients with an implanted Ommaya reservoir. Clin J Oncol Nurs 3:63–67

    CAS  PubMed  Google Scholar 

  31. Lishner M, Scheinbaum R, Messner HA (1991) Intrathecal vancomycin in the treatment of Ommaya reservoir infection by Staphylococcus epidermidis. Scand J Infect Dis 23:101–104

    Article  CAS  PubMed  Google Scholar 

  32. Siegal T, Pfeffer MR, Steiner I (1988) Antibiotic therapy for infected Ommaya reservoir systems. Neurosurgery 22:97–100

    CAS  PubMed  Google Scholar 

  33. Bleyer WA, Pizzo PA, Spence AM, Platt WD, Benjamin DR, Kolins CJ, Poplack DG (1978) The Ommaya reservoir. newly recognized complications and recommendations for insertion and use. Cancer 41:2431–2437

    Article  CAS  PubMed  Google Scholar 

  34. Stone JA, Castillo M, Mukherji SK (1999) Leukoencephalopathy complicating an Ommaya reservoir and chemotherapy. Neuroradiology 41:134–136

    Article  CAS  PubMed  Google Scholar 

  35. Chowdhary SA, Chamberlain MC (2006) An unusual complication of Ommaya reservoirs and intraventricular chemotherapy. Neurology 67(2):319–320

    Article  PubMed  Google Scholar 

  36. Chamberlain MC (2012) Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series. J Neurooncol 109:143–148

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Hopital Roger Salengro, Lille University Hospital, Rue Emile Laine, 59037, Lille, France

    Fahed Zairi, Emilie Le Rhun, Rabih Aboukais & Richard Assaker

  2. Department of Medical Oncology, Oscar Lambret Center, Lille, France

    Emilie Le Rhun & Nicolas Bertrand

  3. Department of Radiology, Oscar Lambret Center, Lille, France

    Thomas Boulanger

  4. Department of Neuro-Oncology Mazarin, Pitie-Salpetriere Hospital, Paris, France

    Sophie Taillibert

  5. Department of Radiation Oncology, Pitie-Salpetriere Hospital, Paris, France

    Sophie Taillibert

  6. Department of Neurology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA

    Marc C. Chamberlain

Authors
  1. Fahed Zairi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emilie Le Rhun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicolas Bertrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas Boulanger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sophie Taillibert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rabih Aboukais
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Richard Assaker
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marc C. Chamberlain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fahed Zairi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zairi, F., Le Rhun, E., Bertrand, N. et al. Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients. J Neurooncol 124, 317–323 (2015). https://doi.org/10.1007/s11060-015-1842-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-015-1842-x

Keywords

Search

Navigation